Clinical Observation of Yiqi Huoxue Jiedu herbs in Improving the Prognosis of Stable Coronary Heart Disease
- Conditions
- Stable Coronary Heart Disease
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1.Meets the diagnostic criteria for stable coronary heart disease
2.Aged between 18-75 years
3.Meets the criteria of moderate or severe angina (CCS classification II, III) or meets at least 2 conditions in 4 conditions including Hs-CRP>3mg/L, high blood pressure (classification II-III), high cholesterol history, and diabetes history
4.singed the consent form
1. Combined with other heart diseases, or severe cardiopulmonary insufficiency (heart function level III or higher, severe pulmonary insufficiency);
2. Combined with Acute cerebrovascular disease;
3. Combined with uncontrolled blood pressure(systolic blood pressure =160mmHg and diastolic blood pressure =100mmHg);
4. Combined with malignant arrhythmia (ventricular tachycardia, supraventricular arrhythmia affecting hemodynamics) which repeated attacks recently;
5. Combined with severe primary diseases such as liver, kidney, and hematopoietic system, acute infectious diseases, and mental illness;
6. Pregnant, planning to get pregnant or lactating women;
7. Have done head, chest and abdominal operation and bleeding tendency in the past 4 week;
8. Participated in other clinical trials in the past 1 month;
9. Allergic constitution or allergic to the known ingredients of the test drug.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Repeated revascularization;Cardiac death;Non-fatal myocardial infarction;
- Secondary Outcome Measures
Name Time Method Other thrombotic complications;Hospitalized for acute myocardial infarction/heart failure/malignant arrhythmia;All-cause death;Cerebral ischemic stroke;